MedPath

Anxiety in Black Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an Sample of Black Men

Completed
Conditions
Prostate Cancer
Interventions
Behavioral: questionnaires of quality of life
Registration Number
NCT00581672
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

This study is being done to see if a standard tool used to check anxiety in white men works well for Black men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If the investigators have a good tool, it is more likely that the investigators can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
224
Inclusion Criteria
  • 18 years of age or older
  • Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
  • Diagnosis of prostate cancer
  • Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
  • Ability to comprehend and complete questionnaires in English
Read More
Exclusion Criteria
  • Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
  • Other non-Black or non-African-American ethnic groups
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
questionnairesquestionnaires of quality of lifeBlack men with prostate cancer
Primary Outcome Measures
NameTimeMethod
To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in Black men with prostate cancer.within one to three weeks of receiving their PSA scores from their physician
Secondary Outcome Measures
NameTimeMethod
To explore the prevalence of distress, anxiety, and depression in Black men with prostate cancer.within one to three weeks of receiving their PSA scores from their physician

Trial Locations

Locations (3)

Downstate Medical Center

🇺🇸

Brooklyn, New York, United States

Kings County Hopsital Center

🇺🇸

Brooklyn, New York, United States

Memorial Sloan Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath